Anticancer Effect of Melatonin via Downregulation of Delta-Like Ligand 4 in Estrogen-Responsive Breast Cancer Cells.

CONCLUSION: It can be concluded that melatonin treatment attenuated DLL4 expression only in estrogen-responsive breast cancer cells and is able to induce apoptosis in breast cancer cells. PMID: 32990541 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32990541?dopt=Abstract

Source: Recent Patents on Anti-Cancer Drug Discovery - October 1, 2020 Category: Cancer & Oncology Tags: Recent Pat Anticancer Drug Discov Source Type: research